Neuroendocrine circuitry and endometriosis: progesterone derivative dampens corticotropin-releasing hormone-induced inflammation by peritoneal cells in vitro

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-13

This study found that dydrogesterone, a progesterone derivative, inhibited corticotropin-releasing hormone-induced peritoneal inflammation in women with endometriosis, suggesting a link between stress mediators and disease progression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text

The study recruited 69 infertile women undergoing diagnostic laparoscopy and compared early-stage (n=30) versus advanced-stage (n=8) endometriosis, measuring serum progesterone, progesterone receptor (PR) expression on CD56+ and CD8+ peritoneal lymphocytes, and cytokine production by peritoneal leukocytes after stimulation with corticotropin-releasing hormone (CRH), the progesterone derivative dydrogesterone, or both. Women with endometriosis had decreased serum progesterone that inversely correlated with pain scores, and advanced disease showed increased frequencies of PR+ CD56+ and CD8+ peritoneal lymphocytes. The TNF/IL-10 cytokine ratio was higher in cells from endometriosis patients and was further increased by CRH, while dydrogesterone stimulation abrogated CRH-mediated inflammation in vitro; PIBF expression by peritoneal leukocytes was also increased in endometriosis. A key limitation is that progesterone effects were assessed in vitro using peritoneal cells rather than demonstrating causality in vivo. This paper is centrally about endometriosis — it examines how neuroendocrine CRH and progesterone/dydrogesterone modulate peritoneal immune inflammatory responses in endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Clinical symptoms of endometriosis, such as pain and infertility, can be described as persistent stressors. Such continuous exposure to stress may severely affect the equilibrium and bidirectional communication of the endocrine and immune system, hereby further aggravating the progression of endometriosis. In the present study, we aimed to tease apart mediators that are involved in the stress response as well as in the progression of endometriosis. Women undergoing diagnostic laparoscopy due to infertility were recruited (n = 69). Within this cohort, early stage of endometriosis were diagnosed in n = 30 and advanced stage of endometriosis in n = 8. Levels of progesterone in serum were determined. Frequency of progesterone receptor (PR) expression on CD56(+) and CD8(+) peritoneal lymphocytes was analysed by flow cytometry. The production of tumour necrosis factor (TNF) and interleukin (IL)-10 by peritoneal leukocytes upon stimulation with the potent stress mediator corticotropin-releasing hormone (CRH) and the progesterone derivative dydrogesterone, or both, were evaluated. Furthermore, the production of progesterone-induced blocking factor (PIBF) by peritoneal leukocytes and the expression of PR in endometriotic tissue were investigated. Levels of progesterone in serum were decreased in women with endometriosis and inversely correlated to pain scores. Furthermore, an increased frequency of CD56(+)PR(+) and CD8(+)PR(+) peritoneal lymphocytes was present in advanced endometriosis. The TNF/IL-10 ratio, reflecting cytokine secretion by peritoneal cells, was higher in cells derived from endometriosis patients and could be further heightened by CRH stimulation, whereas stimulation with dydrogesterone abrogated the CRH-mediated inflammation. Finally, the expression of PIBF by peritoneal leukocytes was increased in endometriosis. Low levels of progesterone in the follicular phase could be responsible for the progression of endometriosis and related pain. Peripheral CRH, increasing upon high psychological stress, might contribute to the peritoneal inflammation present in endometriosis. The therapeutic application of progesterone derivatives, CRH blocking agents as well as improvement of stress coping may disrupt the vicious circle between the chronic peritoneal inflammation and high perception of psychological stress in endometriosis.
Full text 13,895 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Clinical symptoms of endometriosis, such as pain and infertility, can be described as persistent stressors. Such continuous exposure to stress may severely affect the equilibrium and bidirectional communication of the endocrine and immune system, hereby further aggravating the progression of endometriosis. In the present study, we aimed to tease apart mediators that are involved in the stress response as well as in the progression of endometriosis. Women undergoing diagnostic laparoscopy due to infertility were recruited (n = 69). Within this cohort, early stage of endometriosis were diagnosed in n = 30 and advanced stage of endometriosis in n = 8. Levels of progesterone in serum were determined. Frequency of progesterone receptor (PR) expression on CD56+ and CD8+ peritoneal lymphocytes was analysed by flow cytometry. The production of tumour necrosis factor (TNF) and interleukin (IL)-10 by peritoneal leukocytes upon stimulation with the potent stress mediator corticotropin-releasing hormone (CRH) and the progesterone derivative dydrogesterone, or both, were evaluated. Furthermore, the production of progesterone-induced blocking factor (PIBF) by peritoneal leukocytes and the expression of PR in endometriotic tissue were investigated. Levels of progesterone in serum were decreased in women with endometriosis and inversely correlated to pain scores. Furthermore, an increased frequency of CD56+PR+ and CD8+PR+ peritoneal lymphocytes was present in advanced endometriosis. The TNF/IL-10 ratio, reflecting cytokine secretion by peritoneal cells, was higher in cells derived from endometriosis patients and could be further heightened by CRH stimulation, whereas stimulation with dydrogesterone abrogated the CRH-mediated inflammation. Finally, the expression of PIBF by peritoneal leukocytes was increased in endometriosis. Low levels of progesterone in the follicular phase could be responsible for the progression of endometriosis and related pain. Peripheral CRH, increasing upon high psychological stress, might contribute to the peritoneal inflammation present in endometriosis. The therapeutic application of progesterone derivatives, CRH blocking agents as well as improvement of stress coping may disrupt the vicious circle between the chronic peritoneal inflammation and high perception of psychological stress in endometriosis. Similar content being viewed by others

References

Moen MH, Muus KM (1991) Endometriosis in pregnant and non-pregnant women at tubal sterilization. Hum Reprod 6:699–702 Strauss B, Didzus A, Speidel H (1992) A study of the psychosomatic aspects of endometriosis. Psychother Psychosom Med Psychol 42:242–252 Low WY, Edelmann RJ, Sutton C (1993) A psychological profile of endometriosis patients in comparison to patients with pelvic pain of other origins. J Psychosom Res 37:111–116 Siedentopf F, Tariverdian N, Rücke M, Kentenich H, Arck PC (2008) Immune status, psychosocial distress and reduced quality of life in infertile patients with endometriosis. Am J Reprod Immunol 60:449–461 Prentice A, Deary AJ, Bland E (2000) Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev:CD002122 Fujishita A, Nakane PK, Koji T, Masuzaki H, Chavez RO, Yamabe T, Ishimaru T (1997) Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study. Fertil Steril 67:856–864 Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG (2003) Progestogens for endometriosis: forward to the past. Hum Reprod Updat 9:387–396 Overton CE, Lindsay PC, Johal B, Collins SA, Siddle NC, Shaw RW, Barlow DH (1994) A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril 62:701–707 Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M, Koninckx PR (1992) The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 58:290–295 Braun DP, Gebel H, Rotman C, Rana N, Dmowski WP (1992) The development of cytotoxicity in peritoneal macrophages from women with endometriosis. Fertil Steril 57:1203–1210 Ho HN, Chao KH, Chen HF, Wu MY, Yang YS, Lee TY (1995) Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III–IV endometriosis. Hum Reprod 10:2671–2675 Tariverdian N, Siedentopf F, Rucke M, Blois SM, Klapp BF, Kentenich H, Arck PC (2009) Intraperitoneal immune cell status in infertile women with and without endometriosis. J Reprod Immunol 80:80–90 Blois SM, Joachim R, Kandil J, Margni R, Tometten M, Klapp BF, Arck PC (2004) Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile. J Immunol 172:5893–5899 Chiu L, Nishimura M, Ishii Y, Nieda M, Maeshima M, Takedani Y, Shibata Y, Tadokoro K, Juji T (1996) Enhancement of the expression of progesterone receptor on progesterone-treated lymphocytes after immunotherapy in unexplained recurrent spontaneous abortion. Am J Reprod Immunol 35:552–557 Katsuki Y, Takano Y, Futamura Y, Shibutani Y, Aoki D, Udagawa Y, Nozawa S (1998) Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats. Eur J Endocrinol 138:216–226 Qiu BS, Vallance BA, Blennerhassett PA, Collins SM (1999) The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat Med 5:1178–1182 Paus R, Theoharides TC, Arck PC (2006) Neuroimmunoendocrine circuitry of the ‘brain-skin connection’. Trends Immunol 27:32–39 Arck P, Knackstedt MK, Blois SM (2006) Current insights and future perspectives on neuro-endocrine-immune circuitry challenging pregnancy maintenance and fetal health. J Repro Med Endo 3:98–102 Cacioppo JT, Berntson GG, Malarkey WB, Kiecolt-Glaser JK, Sheridan JF, Poehlmann KM, Burleson MH, Ernst JM, Hawkley LC, Glaser R (1998) Autonomic, neuroendocrine, and immune responses to psychological stress: the reactivity hypothesis. Ann N Y Acad Sci 840:664–673 Saunders PR, Santos J, Hanssen NP, Yates D, Groot JA, Perdue MH (2002) Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH. Dig Dis Sci 47:208–215 van Tol EA, Petrusz P, Lund PK, Yamauchi M, Sartor RB (1996) Local production of corticotropin releasing hormone is increased in experimental intestinal inflammation in rats. Gut 39:385–392 Keenan JA, Chen TT, Chadwell NL, Torry DS, Caudle MR (1994) Interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 32:180–183 Keenan JA, Chen TT, Chadwell NL, Torry DS, Caudle MR (1995) IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 34:381–385 Taketani Y, Kuo TM, Mizuno M (1992) Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol 167:265–270 Arck PC, Merali FS, Manuel J, Chaouat G, Clark DA (1995) Stress-triggered abortion: inhibition of protective suppression and promotion of tumor necrosis factor-alpha (TNF-alpha) release as a mechanism triggering resorptions in mice. Am J Reprod Immunol 33:74–80 Kempuraj D, Papadopoulou N, Stanford EJ, Christodoulou S, Madhappan B, Sant GR, Solage K, Adams T, Theoharides TC (2004) Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin. Am J Reprod Immunol 52:267–275 Florio P, Busacca M, Vignali M, Vigano P, Woods RJ, Lowry PJ, Genazzani AR, Luisi S, Santuz M, Petraglia F (1998) Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women. J Endocrinol Investig 21:37–42 Florio P, Reis FM, Torres PB, Calonaci F, Toti P, Bocchi C, Linton EA, Petraglia F (2007) Plasma urocortin levels in the diagnosis of ovarian endometriosis. Obstet Gynecol 110:594–600 Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosmans E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpe S, Smith RS (1998) The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10:313–318 Joachim R, Zenclussen AC, Polgar B, Douglas AJ, Fest S, Knackstedt M, Klapp BF, Arck PC (2003) The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids 68:931–940 Orsal AS, Blois S, Labuz D, Peters EM, Schaefer M, Arck PC (2006) The progesterone derivative dydrogesterone down-regulates neurokinin 1 receptor expression on lymphocytes, induces a Th2 skew and exerts hypoalgesic effects in mice. J Mol Med 84:159–167 Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L, Chaouat G (1989) Immunoregulatory effects of a suppressor factor from healthy pregnant women’s lymphocytes after progesterone induction. Cell Immunol 122:281–294 Srivastava MD, Thomas A, Srivastava BI, Check JH (2007) Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymphoma 48:1610–1617 Szekeres-Bartho J, Par G, Dombay G, Smart YC, Volgyi Z (1997) The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity. Cell Immunol 177:194–199 ASRM (1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67:817–821 Koninckx PR, Meuleman C, Demeyere S, Lesaffre E, Cornillie FJ (1991) Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 55:759–765 Cunha-Filho JS, Gross JL, Bastos de Souza CA, Lemos NA, Giugliani C, Freitas F, Passos EP (2003) Physiopathological aspects of corpus luteum defect in infertile patients with mild/minimal endometriosis. J Assist Reprod Genet 20:117–121 Raghupathy R, Al Mutawa E, Makhseed M, Azizieh F, Szekeres-Bartho J (2005) Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. Bjog 112:1096–1101 Kempuraj D, Papadopoulou NG, Lytinas M, Huang M, Kandere-Grzybowska K, Madhappan B, Boucher W, Christodoulou S, Athanassiou A, Theoharides TC (2004) Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 145:43–48 Kravchenco IV, Furalev VA (1994) Secretion of immunoreactive corticotropin releasing factor and adrenocorticotropic hormone by T- and B-lymphocytes in response to cellular stress factors. Biochem Biophys Res Commun 204:828–834 Merchenthaler I, Hynes MA, Vigh S, Shally AV, Petrusz P (1983) Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord. Brain Res 275:373–377 Kalantaridou SN, Makrigiannakis A, Zoumakis E, Chrousos GP (2004) Stress and the female reproductive system. J Reprod Immunol 62:61–68 Tariverdian N, Theoharides TC, Siedentopf F, Gutierrez G, Jeschke U, Rabinovich GA, Blois SM, Arck PC (2007) Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin Immunopathol 29:193–210 Watkins LR, Maier SF (2000) The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 51:29–57 Luheshi GN, Bluthe RM, Rushforth D, Mulcahy N, Konsman JP, Goldbach M, Dantzer R (2000) Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci 85:127–132 Tokushige N, Markham R, Russell P, Fraser IS (2006) Nerve fibres in peritoneal endometriosis. Hum Reprod 21:3001–3007 Cox H, Henderson L, Wood R, Cagliarini G (2003) Learning to take charge: women’s experiences of living with endometriosis. Complement Ther Nurs Midwifery 9:62–68 Weber C, Arck P, Mazurek B, Klapp BF (2002) Impact of a relaxation training on psychometric and immunologic parameters in tinnitus sufferers. J Psychosom Res 52:29–33

Acknowledgements

We are indebted to the support of the physicians and operation room staff at the DRK Klinikum Westend; without their enthusiasm and continuous support, it would have been impossible to perform the present study. The authors are grateful for the technical support provided by Evelin Hagen, Petra Moschansky and Petra Busse. We also wish to thank Thomas Keil for assistance with statistical analyses. This work was made possible by research grants from the Charité to PCA. This study was integrated in ‘EMBIC’, a Network of Excellence co-financed by the European Commission throughout the FP6 framework programme ‘Life Science, Genomics and Biotechnology for Health’. NT is supported by the German Merit Foundation and a recipient of a Charité stipend. SMB is supported by the Habilitation Program of the Charité. Conflict of interest The authors declare that they have no conflicting interests related to this study. Author information Authors and Affiliations Corresponding author Additional information Friederike Siedentopf and Petra C. Arck jointly supervised this work. Rights and permissions About this article Cite this article Tariverdian, N., Rücke, M., Szekeres-Bartho, J. et al. Neuroendocrine circuitry and endometriosis: progesterone derivative dampens corticotropin-releasing hormone-induced inflammation by peritoneal cells in vitro. J Mol Med 88, 267–278 (2010). https://doi.org/10.1007/s00109-009-0559-8 Received: Revised: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00109-009-0559-8

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

MeSH descriptors

Corticotropin-Releasing Hormone Dydrogesterone Endometriosis Inflammation Mediators Adult Cells, Cultured Cohort Studies Corticotropin-Releasing Hormone Corticotropin-Releasing Hormone Dydrogesterone Endometriosis Endometriosis Endometriosis Female Humans Inflammation Mediators Interleukin-10 Interleukin-10 Neurosecretory Systems Neurosecretory Systems

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-15T06:15:18.721777+00:00
pubmed
last seen: 2026-05-13T22:13:53.633898+00:00
unpaywall
last seen: 2026-08-15T06:29:46.044917+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine